1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Capital Point Ltd.
  6. Summary
    CPTP   IL0010971468

CAPITAL POINT LTD.

(CPTP)
  Report
End-of-day quote TEL AVIV STOCK EXCHANGE  -  05-25
0.8160 ILS   -0.49%
03/30Capital Point Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2020Evero Health Ltd entered into a definitive securities purchase agreement to acquire 35% stake in Coeruleus Ltd from Capital Point Ltd. for ILS 1.2 million.
CI
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Tel Aviv Stock Exchange
05/22/2022 05/23/2022 05/24/2022 05/25/2022 05/26/2022 Date
0.809 0.817 0.826 0.82 0.816 Last
504 14683 128967 301 808 Volume
-0.49% +0.99% +1.10% -0.73% -0.49% Change
Estimated financial data (e)
More Financials
Company
Capital Point Ltd. is an Israel-based holding company with interests in the technological industry. The Company is the majority share holder of MITAG High Tech Ventures Ltd. and Ofakim Hi Tech Ventures Ltd. The two subsidiaries act as privatized peripheral technological hothouses, part of a scheme of privatized hothouses instructed by the head of the Ministry of Industry and Trades. The scheme is there to support... 
More about the company
All news about CAPITAL POINT LTD.
03/30Capital Point Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2020Evero Health Ltd entered into a definitive securities purchase agreement to acquire 35%..
CI
2017RDD Pharma, Ltd. announced that it has received $9.5 million in funding from Pharmascie..
CI
2016Capital Point Ltd. cancelled the acquisition of an additional 19.37% stake in Xenia Ven..
CI
2016Capital Point Ltd. sold 0.83% stake in NeuroDerm Ltd. for $2.3 million.
CI
2016Capital Point Ltd. made an offer to acquire additional 19.37% stake in Xenia Venture Ca..
CI
2016Capital Point Ltd. sold 0.76% stake in NeuroDerm Ltd. for $2.5 million.
CI
2015Capital Point Ltd. sold 0.72% stake in NeuroDerm Ltd. for $3 million.
CI
2015Capital Point Ltd. sold 0.88% stake in NeuroDerm Ltd. for $3.7 million.
CI
2015Dentack Implants Ltd. announced that it has received $0.4 million in funding from Capit..
CI
2013Neuroderm Reportedly Raising $5 Million From Investors
CI
2013righTune announced that it has received $0.70 million in funding from Capital Point Ltd..
CI
More news
News in other languages on CAPITAL POINT LTD.
03/30Capital Point Ltd. annonce ses résultats pour l'année complète se terminant le 31 décem..
More news
Chart CAPITAL POINT LTD.
Duration : Period :
Capital Point Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Yossi Tamar Co-Chief Executive Officer
Shay Itzhack Lior Co-Chief Executive Officer
Avraham Katzav Chief Financial Officer
Yehoshua Jacob Gleitman Chairman
Arye Weber Independent Director
Sector and Competitors